← Back to search
MYELO THERAPEUTICS GMBH
BERLIN, 10115
Unclaimed
Source Records
No company-reported description yet. Owners can add one after claiming the profile.
Capabilities
Derived from government recordsGov-sourced
Prime contracting experience
1 record from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | DEVELOPMENT OF MYELO001 AS AN ORALLY APPLIED MEDICAL COUNTERMEASURE FOR THE TREATMENT OF HEMATOPOIETIC ACUTE RADIATION SYNDROME | — | $6,728,096 | Jan 16, 2025 | May 1, 2020 – Jan 16, 2025 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
No subaward records on record in current sources. Subcontract relationships are never inferred from award keywords.
Agencies supported
- Department of Health and Human ServicesGov-sourced